Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research` Rury R. Holman, MB, ChB, FRCP Professor of Diabetic Medicine Director, Diabetes.
MT For Low-Density Languages Ryan Georgi Ling 575 – MT Seminar Winter 2007.
Recruitment and Retention for Diabetes Prevention Carol Percy, RN, MS Shiprock DPPOS Program Coordinator Roz Barber Shiprock DPP Recruitment and Retention.
Recruitment and Retention for CVD Risk Reduction Carol Percy, RN, MS Shiprock DPPOS Program Coordinator Mary Hoskin, RD, MS Phoenix DPPOS Program Coordinator.
